Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongfeng Qu

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Molecular Therapy Oncolytics|July 9, 2020
DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4Janani Panneerselvam, Priyanga Mohandoss, Ravi Patel, et al.
Oncotarget|September 13, 2015
Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewalParthasarathy Chandrakesan, Randal May, Dongfeng Qu, et al.
Scientific Reports|July 1, 2020
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanismNaushad Ali, Charles B Nguyen, Parthasarathy Chandrakesan, et al.
Journal of Gastroenterology and Hepatology|September 16, 2011
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinomaKenneth J Vega, Randal May, Sripathi M Sureban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodesMasahide Takedachi, Dongfeng Qu, Yukihiko Ebisuno, et al.
Molecular Cancer|February 3, 2017
Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cellsParthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu, et al.
Cancer Research|June 12, 2016
(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle ProgressionCharles B Nguyen, Hari Kotturi, Gulam Waris, et al.
Molecular Cancer|April 19, 2025
Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cellsParthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu, et al.
Cancer Research|June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 KinaseNathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
Journal of Oncology|August 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Molecular Therapy Oncolytics|July 9, 2020
DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4Janani Panneerselvam, Priyanga Mohandoss, Ravi Patel, et al.
Oncotarget|September 13, 2015
Dclk1+ small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewalParthasarathy Chandrakesan, Randal May, Dongfeng Qu, et al.
Scientific Reports|July 1, 2020
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanismNaushad Ali, Charles B Nguyen, Parthasarathy Chandrakesan, et al.
Journal of Gastroenterology and Hepatology|September 16, 2011
Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinomaKenneth J Vega, Randal May, Sripathi M Sureban, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodesMasahide Takedachi, Dongfeng Qu, Yukihiko Ebisuno, et al.
Molecular Cancer|February 3, 2017
Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cellsParthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu, et al.
Cancer Research|June 12, 2016
(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle ProgressionCharles B Nguyen, Hari Kotturi, Gulam Waris, et al.
Molecular Cancer|April 19, 2025
Retraction Note: Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cellsParthasarathy Chandrakesan, Jiannan Yao, Dongfeng Qu, et al.
Cancer Research|June 12, 2016
Survival of Patients with Gastrointestinal Cancers Can Be Predicted by a Surrogate microRNA Signature for Cancer Stem-like Cells Marked by DCLK1 KinaseNathaniel Weygant, Yang Ge, Dongfeng Qu, et al.
Journal of Oncology|August 31, 2019
Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic CancerDongfeng Qu, Nathaniel Weygant, Jiannan Yao, et al.
Pageof 5